3.5 Hearing Loss



10.1055/b-0038-162749

3.5 Hearing Loss



3.5.1 Conductive Hearing Loss



Key Features





  • Conductive hearing loss (CHL) occurs when sound is not efficiently transmitted through the external auditory canal, tympanic membrane, and ossicles to a functioning cochlea.



  • CHL can occur due to dysfunction of the external auditory canal (EAC), the tympanic membrane, or the ossicles.



  • Most cases of CHL can be surgically corrected.


Disorders of the external auditory canal (EAC), tympanic membrane (TM), middle ear, and ossicles can impair sound transmission to a functioning cochlea, resulting in conductive hearing loss (CHL).



Clinical



Signs

Various forms of obstruction can occur at the level of the EAC (e.g., cerumen, foreign body, congenital canal atresia, inflammatory stenosis with acquired atresia, bony exostosis, canal cholesteatoma). Blockage of the EAC can cause up to a 40-dB hearing loss. The TM may be thickened from scarring or tympanosclerosis; it can be retracted from negative middle ear pressure and drape on the incus and stapes (e.g., myringoincudostapediopexy) or even onto the cochlear promontory. In addition, perforations of any size and middle ear effusion may interfere with the proper vibration of the ear drum and cause hearing loss. Interruption of the continuity or mobility of the ossicular chain can also cause CHL; ossicles may be eroded or missing.



Symptoms

Patients will report hearing loss, difficulty understanding speech in noisy environments, and occasionally tinnitus. Disorders of the EAC and TM (e.g., cholesteatoma, chronic otitis media) may also cause otorrhea and recurrent infections. Inciting events may be elicited, such as head trauma, recent upper respiratory tract infection, or flight. Causes of potential auditory (eustachian) tube dysfunction should be elicited, such as chronic sinusitis, allergic rhinitis, or cleft palate.



Differential Diagnosis

The differential diagnosis of CHL is broad and can involve disorders of the EAC, TM, middle ear, and ossicles. Disorders of the EAC include congenital atresia, cerumen, foreign body, exostosis, osteoma, and neoplasm. Disorders of the TM include scarring, tympanosclerosis, retraction, and perforation. Disorders of the middle ear can include adhesions and effusions and may stem from underlying auditory tube dysfunction. Disorders that can cause ossicular discontinuity or ossicular erosion are trauma, cholesteatoma, chronic otitis media, and neoplasm. Otosclerosis and malleus fixation can also impair the vibratory potential of the ossicular chain. Third window disorders such as semicircular canal dehiscence can also cause CHL.



Evaluation



Physical Exam

A full head and neck examination should be performed to elicit signs of underlying sinonasal disease, auditory tube dysfunction, or neoplasm. In an adult with persistent unilateral middle ear effusion, nasopharyngoscopy is performed to rule out nasopharyngeal mass causing auditory tube dysfunction. Binocular microscopic evaluation of the EAC and TM is extremely helpful in identifying pathology of CHL, which may otherwise be missed with a handheld otoscopy. Complete removal of cerumen aids in visualization. Pneumatic otoscopy can assist in determining TM mobility and should always be documented. The integrity of the manubrium of the malleus, long process of the incus, and stapes can also be seen on exam. In general, the Weber test with a 512-Hz tuning fork generally lateralizes to the ear with CHL. Depending on the degree of CHL, the Rinne test will demonstrate bone conduction greater than air conduction (“negative Rinne”).



Imaging

High-resolution computed tomography (CT) of the temporal bones is not necessary in all cases of CHL. CT scan is obtained when there is a chronically draining ear (e.g., chronic otitis media), evidence of cholesteatoma, or mass lesion of the EAC or middle ear or when the cause of CHL is unclear. CT can also be done for surgical planning (e.g., atresia repair). Otosclerotic foci can be demonstrated on CT, although imaging is not necessary in all cases.



Other Tests

Comprehensive audiometry with both air conduction and bone conduction testing should be performed to determine air–bone gap (ABG), which represents the amount of hearing loss attributed to the conductive mechanism. Tympanometry can be performed to determine the mobility of the drum, detecting perforations and middle ear effusions. Acoustic reflexes should be absent. If acoustic reflexes are present in a patient with a conductive hearing loss, superior semicircular canal dehiscence should be suspected. In this case, cervical vestibular evoked myogenic potential (cVEMP) testing can be helpful, as superior semicircular canal dehiscence syndrome patients typically demonstrate larger amplitudes and lower thresholds on cVEMP testing at 500 Hz.



Treatment Options



Medical

Amplification and observation should be offered to patients as a treatment option. Amplification can include hearing aids and soft band (bone conducting hearing aid). Certain conditions may require surgical intervention prior to amplification (e.g., neoplasm, chronic otitis media, cholesteatoma).



Surgical

Surgical intervention can potentially improve hearing when there is a significant ABG. The surgery depends on the etiology of the CHL. Osseointegrated implants (see Chapter 3.5.5) are an alternative treatment for CHL that should be considered when surgery for the underlying disorder may carry high risk to sensorineural component of hearing or facial nerve (e.g., atresia).



Outer Ear



  • Cerumen removal



  • Foreign body removal



  • Canalplasty with or without skin graft (for exostosis or stenosis)



  • Meatoplasty



  • Atresia repair



Tympanic Membrane



  • Myringotomy with or without tympanostomy tube for middle ear effusion



  • Paper patch or fat myringoplasty for small perforation (often office procedures)



  • Tympanoplasty



Middle Ear



  • Ossicular chain reconstruction using remodeled incus or synthetic prosthesis



  • Stapedectomy/stapedotomy



  • Exploratory tympanotomy with or without mastoidectomy




    • Lysis of middle ear adhesions



    • Removal of tympanosclerosis



    • Repair of malleus fixation



    • Removal of cholesteatoma



    • Treat chronic otitis media



    • Removal of neoplasm



Typical Clinical Pictures



Otosclerosis

Otosclerosis is a process in which the stapes loses mobility by excessive bony growth at the oval window. It typically causes a CHL with a distinctive dip in sensorineural levels at 2 kHz, known as Carhart notch. Patients may have tinnitus and progressive hearing loss in one or both ears. Otosclerosis has a bimodal age epidemiology; it usually presents in the early twenties or later in the fifties. Early otosclerosis can be managed with fluoride supplementation, but often the CHL will progress and patients will need to consider amplification or stapes surgery. Stapedectomy or stapedotomy involves removing the superstructure of the stapes, and entering into the inner ear, either by making a fenestration in the footplate (stapedotomy), or partially removing it (stapedectomy). A synthetic prosthesis is then placed into the oval window and attached to the incus to reestablish ossicular transmission of sound waves.



Ossicular Disease

Cholesteatoma, chronic ear infections, and trauma can all cause erosion or disruption of the ossicular chain. After appropriately treating the aforementioned causes, one may evaluate the remaining middle ear structures to determine the appropriate surgical repair. Once the current ossicular status (anatomic and functional integrity of each ossicle) is determined, the appropriate prosthesis can be selected. Prostheses exist for nearly every situation of ossicular disease. Common prostheses include a partial ossicular reconstruction prosthesis (replaces incus and malleus), incus struts (replace incus only), and a total ossicular reconstruction prosthesis (replaces all ossicles).



Complications


Obstructive EAC stenosis after canalplasty may require revision canalplasty. Tympanoplasty has a failure rate of ~15%, and revision tympanoplasty may be necessary; factors that may affect success rate is the size of the TM perforation (e.g., subtotal or total), location (e.g., anterior, marginal), and etiology (e.g., chronic otitis media). Revision surgery may be necessary after ossicular chain reconstruction if the prosthesis shifts and no longer conducts sound effectively. Six months is generally considered the earliest time point at which revision surgery should be considered. Progressive hearing loss 10 to 14 days after stapes surgery may indicate reparative granuloma, and middle ear exploration should be considered.



Outcome and Follow-Up


Water precautions should be observed in the postoperative period. If the TM is grafted or a stapedotomy is performed, caution regarding airline flight should be considered in the immediate postoperative period to avoid TM movement. A postoperative audiogram to determine level of hearing restoration should be performed 6 to 8 weeks after procedure (adequate time for gelatin packing in the middle ear to absorb).



3.5.2 Sensorineural Hearing Loss



Key Features





  • Sensorineural hearing loss (SNHL) is caused by the dysfunction of the sensory (cochlea) or neural components of the auditory system.



  • Asymmetric SNHL may need to be evaluated by MRI or ABR to rule out retrocochlear pathology.



  • Treatment may include amplification, osseointegrated implants, and cochlear implantation


Sensorineural hearing loss (SNHL) can stem from disorders of the cochlea, cochlear nerve, and central auditory processing. It can affect one or both ears. Asymmetrical SNHL is often described as a 10-dB difference in three consecutive pure tone frequencies, a 15-dB difference in two consecutive frequencies, and/or a ≥ 12% point difference in speech recognition.



Clinical



Signs and Symptoms

Patients typically notice difficulty in crowds or with background noise. They may report having to increase the volume of the television or radio to understand. Patients with high-frequency hearing loss may notice difficulty with understanding women or children′s voices. Many patients will not realize they have hearing loss until it has progressed significantly, as the hearing loss is usually very gradual. Often, tinnitus is associated with hearing loss and may be the presenting symptom. Other otologic symptoms, such as otorrhea, aural fullness, and vertigo, may also help identify the etiology of the hearing loss. Inciting events or risk factors for hearing may be present, such as head trauma, acoustic trauma, chronic loud noise exposure, family history of hearing loss, ototoxic drug use, prematurity, prenatal/postnatal infection, barotrauma, and autoimmune disease. A full review of systems concentrating on neurologic or rheumatologic symptoms may also imply the cause.



Differential Diagnosis for Symmetric SNHL


Presbycusis

Slowly progressive bilateral SNHL in the older population (presbycusis) is widely prevalent and is the most common form of SNHL. It is often a familial condition. However, a detailed otologic history may find other factors that may contribute to SNHL.



Noise-Induced Hearing Loss

Exposure to loud noise can lead to permanent hearing threshold shifts. This may happen immediately with extreme exposure (nearby explosion or gunfire) but more commonly occurs slowly over time with repeated exposure to industrial or environmental noise. Patients will often have a typical 4-kHz notch in their audiograms. Patients should be counseled to prevent further noise damage by wearing appropriate hearing protection and minimizing exposure.



Ototoxicity

Exposure to a variety of medications may induce permanent hearing loss ( Table 3.9 ). This hearing loss is typically first noted in the highest frequencies and then progresses to lower pitches. Common agents include aminoglycoside antibiotics, vinca alkaloids, and platinum-based chemotherapeutic agents. Careful monitoring of audiograms during therapy allow for early identification of hearing loss. Prolonged use of high-dose loop diuretics (e.g., furosemide) may also lead to hearing loss. Of note, many ototoxic drugs are also nephrotoxic; therefore, renal function studies should be obtained as well.








Table 3.9 Common ototoxic drugs

Aminoglycoside antibiotics (e.g., streptomycin, gentamicin, neomycin)


Platinum-based chemotherapy (especially cisplatin)


Loop diuretics


Vinca alkaloids (especially vincristine)


Quinine


Salicylates



Hearing Loss Present at Birth

See Fig. 3.11 for a classification overview of hearing loss at birth. About 50% of cases are nonhereditary, from prematurity, sepsis, or TORCH infections (toxoplasmosis, rubella, cytomegalovirus, herpes simplex encephalitis, and otosyphilis). Of the 50% that are congenital hereditary cases, these may be syndromic (one-third of cases) or nonsyndromic (two-thirds of cases); see Table 3.10 . Of the nonsyndromic cases, ~80% are autosomal recessive.

Fig. 3.11 Hearing loss present at birth: a classification overview.
































Table 3.10 Hereditary syndromic hearing loss

Autosomal dominant


Autosomal recessive


Sex-linked


Treacher Collins


Usher


Alport


Goldenhar


Pendred

 

Waardenberg


Jervell-Lange-Nielsen

 

Branchio-oto-renal

   

Stickler

   

Hearing loss may be present at birth due to congenital defects in either the structure or the physiology of the inner ear. Cochlear malformations (e.g., Mondini malformation, common cavity, cochlear hypoplasia, cochlear aplasia) may be associated with various syndromes. Many cases of nonsyndromic congenital hearing loss have been attributed to chromosomal defects in the hair cell protein connexin 26 (Cx 26). Most congenital cases are now discovered early due to universal newborn screening programs. However, certain types, such as enlarged vestibular aqueduct syndrome, may not manifest until later in life. Auditory neuropathy can also cause unilateral or bilateral SNHL.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 19, 2020 | Posted by in OTOLARYNGOLOGY | Comments Off on 3.5 Hearing Loss

Full access? Get Clinical Tree

Get Clinical Tree app for offline access